Management of research Applied R&D to improve patients quality of life
Pronacera Therapeutics offers a high number of specific platforms for pharmacological screening.
These platforms can provide drug screening technology services to research institutes and pharmaceutical companies for new drug research and development in the following areas:
Pharmacological screening of compounds for lysosomal disorders treatment.
Pharmacological screening of compounds for mitochondrial disorders treatment.
Pharmacological screening of compounds for NBIA disorders treatment.
Pharmacological screening of compounds for hypercholesterolemia disease.
© 2015 Pronacera Therapeutics S.L. | Tel. (+34) 954349381 | Email: info@pronacera.com